News and Announcements
Mobilicom’s SkyHopper products used by second largest drone manufacturer
- Published March 14, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Highlights
- Mobilicom announces a new partnership with the world’s second largest electronic aviation and drone manufacturer, Yuneec.
- Under the partnership, Yuneec will release two drone platforms based on the SkyHopper product suite.
- The SkyHopper suite will be rolled out across Yuneecs global sales channels from Q2, 2019.
Mobilicom announces a new partnership with the world’s second largest electronic aviation and drone manufacturer, Yuneec which will incorporate the use of their SkyHopper suite of products. Yuneec currently dominates across five sites worldwide with the sale of one million units per year.
The partnership will see Mobilicom and the SkyHopper suite exposed to key target markets and customers with the release two drone platforms for commercial and government markets, based on the SkyHopper product offerings. Sales will commence in Q2, 2019 through Yuneec’s worldwide sales channels.
The partnership with Yuneec shows the level of high-quality products and technology delivered by Mobilicom and creates an opportunity for long-term value creation.
About Mobilicom Limited (ASX: MOB)
Mobilicom designs, develops and markets solutions for mission-critical and remote mobile private communication networks without the need for, or use of, any existing infrastructure. Mobilicom’s products and technology merge 4G communication with Mobile MESH technologies into a unified solution, with several product families that have been commercially deployed. Mobilicom’s SkyHopper entity targets the Professional, Commercial and Industrial UAV market.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
